NCT06521892
Interventions on Non-prescription Dispensing of Antibiotics in Community Pharmacies
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 6 words Show 5 more changesShow less
- Trial status changed: Unknown → Completed
- Start date moved earlier from Aug 25, 2024 to Jul 11, 2024
- Interventions modified
- Enrollment target: estimated 400 to confirmed 436
- Primary and study completion dates changed from estimate of Aug 25, 2025 to Sep 18, 2025
- Minor Changed Registry marked status Unknown; last known: Enrolling by Invitation
- Minor Primary and study completion dates: Jul 25, 2025 to Aug 25, 2025
- Start date changed from estimate of Jul 25, 2024 to Aug 25, 2024
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Participants in intervention group will receive a packaged-intervention.The intervention was implemented over a four-week period in the intervention group, with measures including centralized offline training(Week 1), continuous online reinforcement learning(Weeks 2-4), facilitation of public supervision channels(Weeks 1-4), and government department coordination(Weeks 1-4).
Participants in control group would receive routine drug supervision and management measures, such as inspections conducted under existing annual or risk-based regulatory arrangements, review of prescription dispensing and pharmacy quality-management records, investigation of public complaints, and corrective or enforcement action when violations were identified. But the control group of pharmacies would not receive any of the study-specific intervention components during the trial.
Behavioral: A multicomponent intervention combining pharmacy staff education, continuous online reinforcement, facilitation of public supervision, and coordination with local drug regulatory authorities
Sites
1 site in 1 country
- Hubei Provincial Drug AdministrationWuhan, Hubei, China